ENGLISH
|
HINDI
APPS
iPhone
|
iPad
|
BlackBerry
|
Android
Nokia
Windows
Network18
Quotes
Quotes
NAVs
News
Messages
People
Notices
Videos
All
FEEDBACK
Facebook
Follow @moneycontrolcom on Twitter
CNBC TV 18
moneycontrol
News
Markets
Mutual Funds
IPO
Commodities
Wealth
Portfolio
Messages
My TV
Tax
Fixed Income
Property
SME
CNBC-TV18
Home
Business
General News
Market Trends
Stocks
Fund News
Personal Finance
Corporate Strategy
Lifestyle
Politics
Legal
Master Your Money
Share
>
Share
Tweet
Share on Tumblr
Coviro Ls Kid
News »
latest
by relevance
Ranbaxy gets marketing nod for paediatric anti-retrovirals
Dec 07, 2007 at 08:30 | Source:
Business Line
Ranbaxy says it has received approval to market two anti-HIV combination paediatric drugs, reports Business Line. Coviro-LS kid and Coviro-LS kid DS, both double Anti-Retroviral (ARV) and fixed dose combinations, dispersible tablets for children, have received manufacturing and marketing approval in the domestic market.
Ranbaxy gets approval to mfg & mkt ARV combination in India
Dec 06, 2007 at 17:08
Ranbaxy receives approval to manufacture and market ARV combination for children in India. The Company has received approval to manufacture and market Coviro-LS kid and Coviro-LS kid DS, both double Anti-Retroviral (ARV) and fixed dose combination, dispersible tablets for children, in India.
Ranbaxy gets marketing nod for paediatric anti-retrovirals
Dec 07, 2007 at 08:30 | Source:
Business Line
Ranbaxy says it has received approval to market two anti-HIV combination paediatric drugs, reports Business Line. Coviro-LS kid and Coviro-LS kid DS, both double Anti-Retroviral (ARV) and fixed dose combinations, dispersible tablets for children, have received manufacturing and marketing approval in the domestic market.
Ranbaxy gets approval to mfg & mkt ARV combination in India
Dec 06, 2007 at 17:08
Ranbaxy receives approval to manufacture and market ARV combination for children in India. The Company has received approval to manufacture and market Coviro-LS kid and Coviro-LS kid DS, both double Anti-Retroviral (ARV) and fixed dose combination, dispersible tablets for children, in India.
Photos »
/
Follow moneycontrol.com
Facebook
Twitter
Google Plus
RSS
Wap SMS
SMS
Alert
iPad
iPhone
Blackberry
OVI
Android
Window